Alessandro M Vannucchi Selected Research

Alessandro M Vannucchi Research Topics

Disease

84	Primary Myelofibrosis (Myelosclerosis) 07/2022 - 06/2004
56	Neoplasms (Cancer) 05/2022 - 05/2002
52	Polycythemia Vera 12/2022 - 09/2005
39	Essential Thrombocythemia 12/2022 - 09/2005
25	Splenomegaly 07/2022 - 12/2007
21	Thrombosis (Thrombus) 12/2021 - 08/2007
16	Anemia 12/2021 - 01/2011
15	Thrombocytopenia (Thrombopenia) 07/2022 - 03/2012
9	Leukemia 01/2020 - 05/2002
8	Pruritus (Itching) 12/2021 - 12/2007
7	Thrombocytosis (Thrombocythemia) 07/2022 - 08/2007
7	Hemorrhage 01/2022 - 01/2008
6	Venous Thrombosis (Deep-Vein Thrombosis) 12/2021 - 07/2012
5	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2021 - 10/2009
5	Fibrosis (Cirrhosis) 04/2014 - 05/2009
4	Disease Progression 01/2020 - 07/2011
4	Leukocytosis (Pleocytosis) 01/2020 - 05/2012
4	Myeloproliferative Disorders (Myeloproliferative Disorder) 10/2019 - 09/2008
4	Fatigue 01/2017 - 07/2011
3	Multiple Myeloma 11/2021 - 03/2005
3	Polycythemia (Erythrocytosis) 01/2020 - 08/2007
3	Infections 01/2020 - 01/2015
3	Hematologic Neoplasms (Hematological Malignancy) 11/2018 - 01/2015
3	Pain (Aches) 01/2017 - 07/2013
2	Systemic Mastocytosis 11/2022 - 12/2021
2	Portal Hypertension 01/2022 - 02/2011
2	Inflammation (Inflammations) 12/2018 - 02/2011
2	Sepsis (Septicemia) 02/2018 - 05/2017
2	Fever (Fevers) 05/2017 - 07/2013
2	Cytopenia 05/2017 - 06/2016
2	Heart Failure 05/2017 - 07/2010
2	Hyperplasia 04/2014 - 05/2009
2	Hypereosinophilic Syndrome (Loeffler Endocarditis) 07/2010 - 12/2009
1	Hypertension (High Blood Pressure) 07/2022
1	Cerebral Hemorrhage 12/2021
1	Eosinophilia 06/2021
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 06/2021
1	Blast Crisis (Blast Phase) 01/2021

Drug/Important Bio-Agent (IBA)

47	ruxolitinibIBA 07/2022 - 03/2012
22	Hydroxyurea (Hydrea)FDA LinkGeneric 12/2022 - 08/2010
13	Janus Kinase InhibitorsIBA 07/2022 - 12/2013
12	Janus KinasesIBA 07/2022 - 11/2010
12	Hemoglobins (Hemoglobin)IBA 12/2021 - 05/2002
10	Pharmaceutical PreparationsIBA 12/2021 - 05/2002
10	CalreticulinIBA 01/2019 - 03/2014
9	Janus Kinase 2IBA 05/2021 - 08/2007
8	fedratinibIBA 01/2022 - 08/2015
8	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2019 - 01/2007
7	CytokinesIBA 01/2020 - 12/2004
7	Syntex adjuvant formulationIBA 12/2017 - 07/2011
6	MicroRNAs (MicroRNA)IBA 01/2019 - 11/2007
5	InterferonsIBA 12/2022 - 01/2017
5	Proteins (Proteins, Gene)FDA Link 01/2021 - 11/2009
4	Janus Kinase 1IBA 10/2021 - 12/2012
4	givinostatIBA 01/2021 - 08/2010
4	Thrombopoietin (c-mpl Ligand)IBA 01/2020 - 06/2004
4	Everolimus FDA Link 11/2017 - 08/2011
4	Immunologic Factors (Immunomodulators)IBA 01/2017 - 02/2011
4	Reticulin (Reticular Fiber)IBA 04/2014 - 05/2009
3	imetelstatIBA 07/2022 - 10/2021
3	Biomarkers (Surrogate Marker)IBA 10/2021 - 02/2011
3	Phosphotransferases (Kinase)IBA 10/2021 - 12/2013
3	AnticoagulantsIBA 10/2021 - 03/2008
3	pomalidomideIBA 01/2021 - 01/2011
3	Histone Deacetylase InhibitorsIBA 01/2020 - 08/2010
3	Biological ProductsIBA 10/2018 - 12/2010
3	anagrelide (Agrylin)FDA LinkGeneric 01/2017 - 12/2011
3	Erythropoietin FDA Link 04/2014 - 06/2011
3	Imatinib Mesylate (Gleevec)FDA Link 11/2010 - 12/2009
2	avapritinibIBA 11/2022 - 12/2021
2	Telomerase (Telomerase Reverse Transcriptase)IBA 07/2022 - 10/2021
2	11- (2- pyrrolidin- 1- ylethoxy)- 14,19- dioxa- 5,7,26- triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa- 1(25),2(26),3,5,8,10,12(27),16,21,23- decaeneIBA 01/2022 - 05/2017
2	Interleukin-3 (Interleukin 3)IBA 01/2020 - 11/2009
2	Thrombopoietin ReceptorsIBA 01/2020 - 12/2010
2	Dihydrotachysterol (AT 10)IBA 01/2019 - 08/2011
2	RNA (Ribonucleic Acid)IBA 01/2015 - 03/2012
2	Messenger RNA (mRNA)IBA 09/2014 - 11/2009
2	TOR Serine-Threonine KinasesIBA 01/2013 - 07/2011
2	bepafantIBA 10/2009 - 05/2002
1	Interleukin-1 Receptor-Associated KinasesIBA 01/2022
1	RG7388IBA 01/2022
1	Busulfan (Busulfex)FDA Link 12/2021
1	VaccinesIBA 12/2021
1	daratumumabIBA 11/2021
1	Cytokine Receptors (Cytokine Receptor)IBA 06/2021
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 06/2021
1	Lenalidomide (CC 5013)FDA Link 01/2021
1	ChromatinIBA 01/2021
1	Oxygen (Dioxygen)IBA 01/2021
1	Azacitidine (5 Azacytidine)FDA Link 01/2021
1	Decitabine FDA Link 01/2021
1	Interleukin-13IBA 01/2021

Therapy/Procedure

54	Therapeutics 12/2022 - 05/2002
5	Splenectomy 01/2021 - 12/2007
3	Drug Therapy (Chemotherapy) 10/2018 - 08/2007
3	Erythrocyte Transfusion 02/2018 - 01/2017
2	Hematopoietic Stem Cell Transplantation 01/2020 - 08/2014
2	Drug Tapering 02/2018 - 03/2012
2	Stem Cell Transplantation 01/2018 - 03/2009
1	Surgical Portasystemic Shunt (Portosystemic Shunt) 01/2022